1998, Current topics in microbiology and immunology, ISBN 9783540633921, Volume 226., xiii, 198
Book
2.
DNA pharmaceuticals
: formulation and delivery in gene therapy, DNA vaccination and immunotherapy
2005, ISBN 9783527311873, xxii, 253
Book
1998, Principles and practice., ISBN 3540644288, x, 180
Book
International Journal of Cancer, ISSN 0020-7136, 02/2010, Volume 126, Issue 4, pp. 909 - 918
Peptide‐based vaccines have led to the induction of antigen‐specific CD8+ T‐cell responses in patients with NY‐ESO‐1 positive cancers. However, vaccine‐induced...
immune response | clinical outcome | peptide‐based vaccination | adjuvants | Clinical outcome | Peptide-based vaccination | Adjuvants | Immune response | HUMORAL IMMUNE-RESPONSES | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | peptide-based vaccination | MELANOMA PATIENTS | OVARIAN-CANCER | CANCER-PATIENTS | ONCOLOGY | PHASE-I TRIAL | PROSTATE-CANCER | TESTIS ANTIGEN NY-ESO-1 | BACTERIAL-DNA | Immunotherapy - methods | Sarcoma - immunology | Breast Neoplasms - immunology | Oleic Acids - therapeutic use | Humans | Mannitol - therapeutic use | Ovarian Neoplasms - pathology | Membrane Proteins - therapeutic use | Sarcoma - pathology | Mannitol - analogs & derivatives | Cancer Vaccines - therapeutic use | Flow Cytometry | Vaccination - methods | Antigens, Neoplasm - therapeutic use | Breast Neoplasms - pathology | Melanoma - immunology | Neoplasms - immunology | Cell Line, Tumor | Female | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Oligodeoxyribonucleotides - therapeutic use | Ovarian Neoplasms - immunology
immune response | clinical outcome | peptide‐based vaccination | adjuvants | Clinical outcome | Peptide-based vaccination | Adjuvants | Immune response | HUMORAL IMMUNE-RESPONSES | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | peptide-based vaccination | MELANOMA PATIENTS | OVARIAN-CANCER | CANCER-PATIENTS | ONCOLOGY | PHASE-I TRIAL | PROSTATE-CANCER | TESTIS ANTIGEN NY-ESO-1 | BACTERIAL-DNA | Immunotherapy - methods | Sarcoma - immunology | Breast Neoplasms - immunology | Oleic Acids - therapeutic use | Humans | Mannitol - therapeutic use | Ovarian Neoplasms - pathology | Membrane Proteins - therapeutic use | Sarcoma - pathology | Mannitol - analogs & derivatives | Cancer Vaccines - therapeutic use | Flow Cytometry | Vaccination - methods | Antigens, Neoplasm - therapeutic use | Breast Neoplasms - pathology | Melanoma - immunology | Neoplasms - immunology | Cell Line, Tumor | Female | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Oligodeoxyribonucleotides - therapeutic use | Ovarian Neoplasms - immunology
Journal Article
Cancer Research, ISSN 0008-5472, 2012, Volume 72, Issue 5, pp. 1081 - 1091
Multiple genetic events and subsequent clonal evolution drive carcinogenesis, making disease elimination with single-targeted drugs difficult. The multiplicity...
BREAST-CANCER | REJECTION ANTIGEN | POINT MUTATION | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | B16 MELANOMA | ONCOLOGY | HUMAN-MELANOMA | PEPTIDE VACCINE | T-LYMPHOCYTES | INCOMPLETE FREUNDS-ADJUVANT | Point Mutation - immunology | Cancer Vaccines - classification | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Vaccination | Epitopes - genetics | Sequence Analysis, DNA | Cancer Vaccines - genetics | Exome | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Animals | Melanoma, Experimental - genetics | Melanoma, Experimental - immunology | Cell Line, Tumor | Female | Mice
BREAST-CANCER | REJECTION ANTIGEN | POINT MUTATION | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | B16 MELANOMA | ONCOLOGY | HUMAN-MELANOMA | PEPTIDE VACCINE | T-LYMPHOCYTES | INCOMPLETE FREUNDS-ADJUVANT | Point Mutation - immunology | Cancer Vaccines - classification | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Vaccination | Epitopes - genetics | Sequence Analysis, DNA | Cancer Vaccines - genetics | Exome | Cancer Vaccines - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Animals | Melanoma, Experimental - genetics | Melanoma, Experimental - immunology | Cell Line, Tumor | Female | Mice
Journal Article
Current Opinion in Immunology, ISSN 0952-7915, 2009, Volume 21, Issue 3, pp. 346 - 351
An effective vaccine usually requires more than one time immunization in the form of prime–boost. Traditionally the same vaccines are given multiple times as...
Allergy and Immunology | DNA PRIME | IMMUNOGENICITY | NEUTRALIZING ANTIBODIES | CELLULAR IMMUNE-RESPONSES | COMBINATION DNA | GP120 PROTEIN | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | SUBTYPE-B | RHESUS MACAQUES | HIV Infections - prevention & control | Cancer Vaccines - administration & dosage | HIV Infections - virology | Humans | AIDS Vaccines - immunology | Immunization, Secondary - methods | Neoplasms - prevention & control | Research - trends | Cancer Vaccines - immunology | HIV Infections - immunology | Animals | Vaccination - methods | Neoplasms - immunology | AIDS Vaccines - administration & dosage | Research Design | Antigens | Vaccination
Allergy and Immunology | DNA PRIME | IMMUNOGENICITY | NEUTRALIZING ANTIBODIES | CELLULAR IMMUNE-RESPONSES | COMBINATION DNA | GP120 PROTEIN | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | TYPE-1 | SUBTYPE-B | RHESUS MACAQUES | HIV Infections - prevention & control | Cancer Vaccines - administration & dosage | HIV Infections - virology | Humans | AIDS Vaccines - immunology | Immunization, Secondary - methods | Neoplasms - prevention & control | Research - trends | Cancer Vaccines - immunology | HIV Infections - immunology | Animals | Vaccination - methods | Neoplasms - immunology | AIDS Vaccines - administration & dosage | Research Design | Antigens | Vaccination
Journal Article
Nature Materials, ISSN 1476-1122, 2013, Volume 12, Issue 4, pp. 367 - 376
DNA vaccines have many potential benefits but have failed to generate robust immune responses in humans. Recently, methods such as in vivo electroporation have...
PHYSICS, CONDENSED MATTER | ELECTROPORATION | PHYSICS, APPLIED | DENDRITIC CELLS | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | RELEASE | DELIVERY | IMMUNIZATION | FILMS | PLASMID DNA | MICRONEEDLES | MYELOPEROXIDASE ACTIVITY | VACCINES | Vaccines, DNA - chemistry | Animals | Vaccination - methods | Adjuvants, Immunologic - chemistry | Humans | Vaccines, DNA - immunology | Polymers - chemistry | Mice | Electroporation - methods | Injections, Intradermal | Skin - immunology | Biotechnology | Immunology | Transplants & implants | Materials science | Vaccines | Polymers | Deoxyribonucleic acid--DNA
PHYSICS, CONDENSED MATTER | ELECTROPORATION | PHYSICS, APPLIED | DENDRITIC CELLS | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | RELEASE | DELIVERY | IMMUNIZATION | FILMS | PLASMID DNA | MICRONEEDLES | MYELOPEROXIDASE ACTIVITY | VACCINES | Vaccines, DNA - chemistry | Animals | Vaccination - methods | Adjuvants, Immunologic - chemistry | Humans | Vaccines, DNA - immunology | Polymers - chemistry | Mice | Electroporation - methods | Injections, Intradermal | Skin - immunology | Biotechnology | Immunology | Transplants & implants | Materials science | Vaccines | Polymers | Deoxyribonucleic acid--DNA
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 30, Issue 3, pp. 523 - 538
Highlights ► The skin is an attractive and easily accessible target for vaccination. ► Needle-free vaccination requires novel devices for effective targeting...
Allergy and Immunology | Ballistic injection | Intradermal vaccination | Microinjection | Liquid jet injection | Microneedle | MEDICINE, RESEARCH & EXPERIMENTAL | TRANSDERMAL DELIVERY | B SURFACE-ANTIGEN | IMMUNOLOGY | SEASONAL INFLUENZA VACCINE | INACTIVATED POLIOVIRUS VACCINE | DNA VACCINE | EPIDERMAL POWDER IMMUNIZATION | TRANSCUTANEOUS IMMUNIZATION | VIRUS-LIKE PARTICLES | FREE JET INJECTIONS | ANTIBODY-RESPONSES | Vaccination - methods | Equipment and Supplies | Injections, Intradermal - methods | Vaccines - administration & dosage | Humans | Drug Delivery Systems | Vaccination | Skin | Public health | Hepatitis | Pain | Influenza | Clinical trials | Vaccines | Appropriate technology | Developing countries--LDCs | Immune system
Allergy and Immunology | Ballistic injection | Intradermal vaccination | Microinjection | Liquid jet injection | Microneedle | MEDICINE, RESEARCH & EXPERIMENTAL | TRANSDERMAL DELIVERY | B SURFACE-ANTIGEN | IMMUNOLOGY | SEASONAL INFLUENZA VACCINE | INACTIVATED POLIOVIRUS VACCINE | DNA VACCINE | EPIDERMAL POWDER IMMUNIZATION | TRANSCUTANEOUS IMMUNIZATION | VIRUS-LIKE PARTICLES | FREE JET INJECTIONS | ANTIBODY-RESPONSES | Vaccination - methods | Equipment and Supplies | Injections, Intradermal - methods | Vaccines - administration & dosage | Humans | Drug Delivery Systems | Vaccination | Skin | Public health | Hepatitis | Pain | Influenza | Clinical trials | Vaccines | Appropriate technology | Developing countries--LDCs | Immune system
Journal Article
Veterinary Research, ISSN 0928-4249, 09/2017, Volume 48, Issue 1, pp. 57 - 26
RABORAL V-RG (R) is an oral rabies vaccine bait that contains an attenuated ("modified-live") recombinant vaccinia virus vector vaccine expressing the rabies...
RACCOONS PROCYON-LOTOR | UNITED-STATES | RED FOXES | SYLVATIC RABIES | AERIAL DISTRIBUTION | SKUNKS MEPHITIS-MEPHITIS | HUMORAL IMMUNE-RESPONSE | STRIPED SKUNKS | VETERINARY SCIENCES | FOXES VULPES-VULPES | FIELD TRIAL | Rabies - prevention & control | Rabies virus - genetics | Animals | Rabies - veterinary | Rabies Vaccines - administration & dosage | Administration, Oral | Rabies Vaccines - therapeutic use | Animals, Wild - virology | Vaccines, Synthetic - therapeutic use | Vaccinia virus - genetics | Genetic vectors | Wildlife | Vaccination | Rabies | Research | Health aspects | Vaccinia | Proteins | Bats | Surveillance | Collaboration | Viruses | Glycoproteins | Genomes | Vaccines | Mammals | Deoxyribonucleic acid--DNA | Life Sciences | Review
RACCOONS PROCYON-LOTOR | UNITED-STATES | RED FOXES | SYLVATIC RABIES | AERIAL DISTRIBUTION | SKUNKS MEPHITIS-MEPHITIS | HUMORAL IMMUNE-RESPONSE | STRIPED SKUNKS | VETERINARY SCIENCES | FOXES VULPES-VULPES | FIELD TRIAL | Rabies - prevention & control | Rabies virus - genetics | Animals | Rabies - veterinary | Rabies Vaccines - administration & dosage | Administration, Oral | Rabies Vaccines - therapeutic use | Animals, Wild - virology | Vaccines, Synthetic - therapeutic use | Vaccinia virus - genetics | Genetic vectors | Wildlife | Vaccination | Rabies | Research | Health aspects | Vaccinia | Proteins | Bats | Surveillance | Collaboration | Viruses | Glycoproteins | Genomes | Vaccines | Mammals | Deoxyribonucleic acid--DNA | Life Sciences | Review
Journal Article
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7644, pp. 248 - 251
Zika virus (ZIKV) has recently emerged as a pandemic associated with severe neuropathology in newborns and adults(1). There are no ZIKV-specific treatments or...
THERAPEUTICS | LIPID NANOPARTICLES | IMMUNITY | THERAPY | SPECIFICITY | PSEUDOURIDINE | MULTIDISCIPLINARY SCIENCES | INFECTION | EXPRESSION | VECTORS | VACCINES | Zika Virus - genetics | Nanoparticles - chemistry | Vaccination | Macaca mulatta - immunology | RNA, Viral - administration & dosage | Antigens, Viral - genetics | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | RNA, Viral - genetics | Time Factors | RNA, Messenger - administration & dosage | Female | Zika Virus Infection - prevention & control | Injections, Intradermal | Glycoproteins - genetics | Zika Virus - immunology | Viral Envelope Proteins - genetics | Mice, Inbred C57BL | RNA, Messenger - genetics | RNA Stability | Zika Virus - chemistry | Viral Vaccines - administration & dosage | Antigens, Viral - immunology | Glycoproteins - immunology | Animals | RNA, Viral - chemistry | Zika Virus Infection - immunology | Antibodies, Viral - immunology | RNA, Messenger - chemistry | Viral Envelope Proteins - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Viral Vaccines - immunology | Messenger RNA | Research | Proteins | Studies | Dendritic cells | Guillain-Barre syndrome | Adenoviruses | Infections | Zika virus | Vaccines | Deoxyribonucleic acid--DNA
THERAPEUTICS | LIPID NANOPARTICLES | IMMUNITY | THERAPY | SPECIFICITY | PSEUDOURIDINE | MULTIDISCIPLINARY SCIENCES | INFECTION | EXPRESSION | VECTORS | VACCINES | Zika Virus - genetics | Nanoparticles - chemistry | Vaccination | Macaca mulatta - immunology | RNA, Viral - administration & dosage | Antigens, Viral - genetics | Macaca mulatta - virology | Antibodies, Neutralizing - immunology | RNA, Viral - genetics | Time Factors | RNA, Messenger - administration & dosage | Female | Zika Virus Infection - prevention & control | Injections, Intradermal | Glycoproteins - genetics | Zika Virus - immunology | Viral Envelope Proteins - genetics | Mice, Inbred C57BL | RNA, Messenger - genetics | RNA Stability | Zika Virus - chemistry | Viral Vaccines - administration & dosage | Antigens, Viral - immunology | Glycoproteins - immunology | Animals | RNA, Viral - chemistry | Zika Virus Infection - immunology | Antibodies, Viral - immunology | RNA, Messenger - chemistry | Viral Envelope Proteins - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Viral Vaccines - immunology | Messenger RNA | Research | Proteins | Studies | Dendritic cells | Guillain-Barre syndrome | Adenoviruses | Infections | Zika virus | Vaccines | Deoxyribonucleic acid--DNA
Journal Article
2001, ISBN 3527302697, xix, 287
Book
OncoImmunology, ISSN 2162-4011, 07/2018, Volume 7, Issue 7, p. e1442163
Memory CD8 + T cell responses have the potential to mediate long-lasting protection against cancers. Resident memory CD8 + T (Trm) cells stably reside in...
Cancer vaccines | protein vaccines | intradermal vaccination | tissue resident memory CD8 | models of anticancer vaccination | melanoma | DNA vaccines | + | T cells | DENDRITIC CELLS | TISSUE | DOWN-REGULATION | OVARIAN-CANCER | IMMUNOLOGY | CUTTING EDGE | tissue resident memory CD8(+) T cells | TUMOR-INFILTRATING LYMPHOCYTES | BREAST-CANCER | LUNG-CANCER | DNA VACCINE | ONCOLOGY | ANTITUMOR IMMUNITY
Cancer vaccines | protein vaccines | intradermal vaccination | tissue resident memory CD8 | models of anticancer vaccination | melanoma | DNA vaccines | + | T cells | DENDRITIC CELLS | TISSUE | DOWN-REGULATION | OVARIAN-CANCER | IMMUNOLOGY | CUTTING EDGE | tissue resident memory CD8(+) T cells | TUMOR-INFILTRATING LYMPHOCYTES | BREAST-CANCER | LUNG-CANCER | DNA VACCINE | ONCOLOGY | ANTITUMOR IMMUNITY
Journal Article